Exploring mTOR Inhibitors for Treating Proliferative Vitreoretinopathy

This chapter delves into the role of mTOR inhibitors in addressing proliferative vitreoretinopathy (PVR) and highlights the necessity of randomized clinical trials for validating these findings. The discussion reflects a growing optimism in the retina surgery community towards innovative treatment solutions for PVR amid recent scientific advancements.